GIVLAARI
NDC 71336-1001, givosiran sodium, injection, solution, from Alnylam Pharmaceuticals, Inc..
- Product NDC
- 71336-1001
- Status
- Listed
- Labeler
- Alnylam Pharmaceuticals, Inc.
- Dosage form
- INJECTION, SOLUTION
- Route
- SUBCUTANEOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA212194
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/71336-1001 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- GIVOSIRAN SODIUM189 mg/mL
Pharmacologic classes
Aminolevulinate Synthase 1-directed RNA Interaction [EPC]; Decreased RNA Integrity [PE]; RNA, Small Interfering [CS]; Small Interfering RNA [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 71336-1001-1 | 71336100101 | 1 VIAL, SINGLE-USE in 1 CARTON (71336-1001-1) / 1 mL in 1 VIAL, SINGLE-USE |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/167e663c-11e1-497b-a3fc-951d65d58eaaMedicare Part B payment limits (ASP)
GET /v1/drugs/asp?ndc=71336-1001
Use it
Look up 71336-1001 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/71336-1001 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 71336-1001. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.